Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
BRIEF-Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer

BRIEF-Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer

ReutersReuters2026/08/18 13:05
By:Reuters

Oncolytics Biotech Inc ONCY.O:

  • ONCOLYTICS BIOTECH® ALIGNS WITH FDA ON REGISTRATIONAL PATH FOR SECOND-LINE RAS-MUTANT MSS COLORECTAL CANCER

  • ONCOLYTICS BIOTECH - RECEIVES FDA FEEDBACK ON PIVOTAL PART B EXPANSION OF REO 033

Source text: ID:nGNX2J99Dk

Further company coverage: ONCY.O


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!